Health-related quality of life and work productivity in Japanese patients with primarily stable ANCA-associated vasculitis: A multicenter cross-sectional study
Modern Rheumatology · 2025
DOI: 10.1093/mr/roaf044 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Modern Rheumatology, 2025. Verfasst von Shinya Hirahara und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Tokyo Women's Medical University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Quality of Life, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Efficiency. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: JSPS KAKENHI, Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Objectives
We aimed to investigate the health-related quality of life (HRQoL) and work productivity of Japanese patients with antineutrophil cytoplasmic antibody -associated vasculitis (AAV).
Methods
We conducted a cross-sectional study of Japanese patients with AAV at three university hospitals using the HRQoL and Work Productivity and Activity Impairment questionnaires.
Results
Ninety-two patients with AAV participated. The values of all eight subscale scores and physical component summary and role component summary scores of the Medical Outcomes Study Short Form-36 and the 5-level EuroQoL 5-Dimensions Questionnaire index values of the AAV patients were significantly lower than the Japanese population norms. The Birmingham Vasculitis Activity Score and Vasculitis Damage Index were weakly and negatively correlated with the Short Form-36 physical component summary scores. Among the 25 patients with AAV who worked for pay, the absenteeism and presenteeism due to AAV were 17% and 32%, respectively, and were mild-to-moderately and negatively correlated with the Short Form-36 physical component summary and role component summary scores and the 5-level EuroQoL 5-Dimensions Questionnaire index values.
Conclusion
The HRQoL of Japanese patients with AAV was poorer than that of the general population and was partly associated with disease activity and damage accrual. In employed patients, impaired work productivity was observed and negatively associated with HRQoL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Rheumatology, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.
- Department of Clinical Epidemiology, Kochi Medical School, Nankoku, Japan.
- Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, 162-8666, Japan.
- Department of Rheumatology and Allergology, St. Marianna University School of Medicine, Kawasaki, Japan.
- Sanno Medical Centre, Tokyo, Japan; Department of Rheumatology, International University of Health and Welfare School of Medicine, Narita, Chiba, Japan.
ORCID-Profile: Yasuhiro Katsumata, Ken-Ei Sada, Hiroko Nagafuchi, Masayoshi Harigai
Förderung
- JSPS KAKENHI
- Japan Agency for Medical Research and Development
Zitieren
APA
Hirahara, S., Katsumata, Y., Sada, K. E., Nagafuchi, H., Tanaka, E., & Harigai, M. (2025). Health-related quality of life and work productivity in Japanese patients with primarily stable ANCA-associated vasculitis: A multicenter cross-sectional study. Modern Rheumatology. https://doi.org/10.1093/mr/roaf044
Vancouver
Hirahara S, Katsumata Y, Sada KE, Nagafuchi H, Tanaka E, Harigai M. Health-related quality of life and work productivity in Japanese patients with primarily stable ANCA-associated vasculitis: A multicenter cross-sectional study. Modern Rheumatology. 2025. doi:10.1093/mr/roaf044
BibTeX
@article{Hirahara2025,
author = {Hirahara, Shinya and Katsumata, Yasuhiro and Sada, Ken-Ei and Nagafuchi, Hiroko and Tanaka, Eiichi and Harigai, Masayoshi},
title = {Health-related quality of life and work productivity in Japanese patients with primarily stable ANCA-associated vasculitis: A multicenter cross-sectional study},
journal = {Modern Rheumatology},
year = {2025},
doi = {10.1093/mr/roaf044}
}
EUVIMED